Personalized treatment for high-risk endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a treatment plan tailored to your specific type of high-risk endometrial (uterine) cancer. It may help by matching therapy to your cancer features and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 100 years old
- Your overall day-to-day function is fairly good (WHO status 0 to 2)
- Your endometrial cancer is stage I to II and labeled high-intermediate or high-risk by special test results
- You have not had another cancer diagnosis in the last 5 years
- You have not had radiation treatment to the pelvis before
- Your treatment start timing after surgery is not too delayed (generally within 30 days for chemo, or within 8 weeks for radiation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how to guide follow-up (adjuvant) treatment after surgery for certain early-stage, higher-risk endometrial cancer. It may help by tailoring care based on patient and tumor details to lower the chance of the cancer coming back.
This trial tests whether adding an immunotherapy drug called durvalumab to the usual treatment can improve outcomes for people with a specific genetic type of endometrial cancer that is at high risk of returning. It is designed for people who have already had surgery to remove the cancer.
This study tests whether using genetic information (molecular classification) along with standard factors helps decide if you should have radiation after surgery for early-stage uterine cancer. It aims to improve treatment and reduce side effects.
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
This study compares different ways of giving radiation and chemotherapy after surgery for stage III endometrial (uterine) cancer. It aims to find which approach works best to reduce cancer risk and improve outcomes.
This trial tests whether radiation therapy after surgery is safe and effective for early-stage endometrial cancer. It is designed for patients with certain molecular subtypes and who have not had chemotherapy.
Hear when a new Endometrial Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.